Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

World Health Organization/International Society of Urological Pathology µî±Þü°è¿¡ µû¸¥ ¹æ±¤ ¿ä·Î»óÇǾÏÁ¾ÀÇ Áõ½ÄÇ¥ÁöÀڷμ­ Ki-67 ¹ßÇö ¹× ¼¼Æ÷ÀÚ¸ê»ç¿Í ºñ±³ÇÑ DNA topoisomerase II-¥áÀÇ ¹ßÇö ¾ç»ó Expression of DNA Topoisomerase II-¥á as a Proliferating Marker in Urothelial Carcinoma of Urinary Bladder based on World Health Organization/International Society of Urological Pathology Consensus Classification: A Correlation with Expression of Ki-67

´ëÇѺ´¸®ÇÐȸÁö 2002³â 36±Ç 5È£ p.305 ~ 313
ÀÌÅÂÁø, À̵¿±â, ¹Ú¾ð¼·, À¯ÀçÇü,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÅÂÁø ( Lee Tae-Jin ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

À̵¿±â ( Lee Dong-Ki ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹Ú¾ð¼· ( Park Eon-Sub ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
À¯ÀçÇü ( Yoo Jae-Hyung ) 
Áß¾Ó´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background: DNA topoisomerase II-alpha is linked with active cell proliferation in mammalian cells. The aim of this study was to examine the relationship between the expression of DNA topoisomerase II-alpha as a proliferating marker, and the expression of Ki-67 and apoptosis in urothelial carcinoma of urinary bladder based on World Health Organization/International Society of Urological Pathology (WHO/ISUP) consensus classification.

Methods: 73 urothelial carcinomas of the urinary bladder after transurethral resection and 25 carcinomas after radical cystectomy were investigated for histologic grading based on WHO and WHO/ISUP consensus classification. Formalin fixed, paraffin embedded tissue of 98 specimens from 73 patients were immunohistochemically stained for DNA topoisomerase II-alpha and Ki-67, and in situ TdT-mediated dUTP-biotin nick end labeling method for evaluation of apoptotic cells was performed. For each case, a DNA topoisomerase II-alpha, Ki-67, and apoptotic indices were determined.

Results: The histologic grades of 73 cases based on the WHO grading system were 21.9% (16 cases) in grade 1, 65.8% (48 cases) in grade 2, and 12.3% (9 cases). 5.5% (4 cases) of papillary neoplasm of low malignant potential, 47.9% (35 cases) of urothelial carcinoma of low grade, and 46.6% (34 cases) in urothelial carcinoma of high grade were reclassified using the WHO/ISUP consensus classification. Histologic grades based on two grading systems were correlated to invasion and stage (p<0.05). DNA topoisomerase II-alpha, Ki-67, and apoptotic indices were correlated to histologic grades based on two grading system and invasion. Also, the correlation of DNA topoisomerase II-alpha and Ki-67 indices, and DNA topoisomerase II-alpha and apoptotic indices were significant, respectively.

Conclusion: DNA topoisomerase II-alpha appears to be an useful marker for assessing the proliferation potential of urothelial carcinoma of in the urinary bladder.

Å°¿öµå

Carcinoma;Transitional Cell;DNA Topoisomerase;Type ll;Ki-67 Antigen;Apoptosis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS